| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/16/2002 | CN1077796C Drugging-abstaining and physique enhancing Chinese medicinal preparation |
| 01/16/2002 | CN1077795C Chinese patent medicine-szechan lovge rhizome and dehurian angelica root liquid for treating headache |
| 01/15/2002 | USRE37516 Acetamide derivative having defined particle size |
| 01/15/2002 | US6339160 For therapy of tumoral growth and metastatization, aterosclerosis, multiple sclerosis, alzheimer's disease, osteoporosis, hypertension, rheumatoid arthritis and other inflammatory diseases |
| 01/15/2002 | US6339106 Methods and compositions for the treatment and prevention of sexual dysfunction |
| 01/15/2002 | US6339101 Administering n-linked sulfonamide of an n-heterocyclic carboxylic acid derivative for therapy of nerve-related vision disorder, improving vision, therapy memory impairment or enhancing memory performance in an animal |
| 01/15/2002 | US6339095 Therapeutic use of 1, 6-dimethyl-8β-hydroxymethyl-10-α-methoxyergoline |
| 01/15/2002 | US6339094 2-acylaminopropanamines as tachykinin receptor antagonists |
| 01/15/2002 | US6339093 For therapy of neurodegeneration; used as nmda(n-methyl-d-aspartate)-receptor subtype selective blockers |
| 01/15/2002 | US6339086 Administering n-desmethylzopiclone, or its pharmaceutically acceptable salt, solvate, hydrate, or clathrate for prophylaxis or therapy of anxiety |
| 01/15/2002 | US6338963 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 01/15/2002 | US6338953 Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein |
| 01/15/2002 | US6338848 Treating multiple sclerosis with immunoglobulins and interleukins |
| 01/15/2002 | CA2160132C Use of steroid antagonists for the therapy and prophylaxis of demential illnesses |
| 01/15/2002 | CA2067243C Compositions and methods for weight reduction |
| 01/15/2002 | CA2039826C Spiro bridged and unbridged heterocyclic compounds |
| 01/14/2002 | CA2353035A1 A process for the preparation of 2-phenyl-imidazo[1,2-a]pyridine-3-acetamides |
| 01/10/2002 | WO2002003684A2 Combination for treating psychoses, comprising an antipsychotic and a muscarinic agonist |
| 01/10/2002 | WO2002003073A1 Differential diagnosis of neurological diseases |
| 01/10/2002 | WO2002003071A2 Modulators of trk protein activity, compositions and uses |
| 01/10/2002 | WO2002002797A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 01/10/2002 | WO2002002780A2 Human serine-threonine kinase |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002773A2 Dual specificity antibodies and methods of making and using |
| 01/10/2002 | WO2002002771A2 Human sparc-homologous (hsparc-h1) gene and methods and uses thereof |
| 01/10/2002 | WO2002002770A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/10/2002 | WO2002002757A2 Adenylyl and guanylyl cyclases |
| 01/10/2002 | WO2002002755A2 Regulation of human thimet oligopeptidase-like enzyme |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002638A2 Methods for treating rheumatic diseases using a soluble ctla4 molecule |
| 01/10/2002 | WO2002002635A2 Isolated human ion channel proteins, nucleic acid molecules encoding them, and uses thereof |
| 01/10/2002 | WO2002002634A2 Human extracellular matrix and cell adhesion polypeptides |
| 01/10/2002 | WO2002002633A2 Transporters and ion channels |
| 01/10/2002 | WO2002002629A2 Grf2-binding proteins and applications thereof |
| 01/10/2002 | WO2002002610A2 Secretion and trafficking molecules |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002603A2 Protein modification and maintenance molecules |
| 01/10/2002 | WO2002002600A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF |
| 01/10/2002 | WO2002002592A1 Memory-enhancing peptides and the use thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002568A1 Pyrimidine derivatives and their use for preventing and treating cerebral ischaemia |
| 01/10/2002 | WO2002002567A1 Thienopyrrolidinones |
| 01/10/2002 | WO2002002564A1 Aryl and heteroaryl diazabicycloalkanes, their preparation and use |
| 01/10/2002 | WO2002002559A1 Steric isomers of fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 01/10/2002 | WO2002002556A2 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 01/10/2002 | WO2002002554A1 Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders |
| 01/10/2002 | WO2002002551A1 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors |
| 01/10/2002 | WO2002002549A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
| 01/10/2002 | WO2002002548A1 Coumarin derivatives with comt inhibiting activity |
| 01/10/2002 | WO2002002541A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002531A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists |
| 01/10/2002 | WO2002002520A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002518A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002511A1 Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness |
| 01/10/2002 | WO2002002506A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002505A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2002002190A2 Prevention and treatment of neurodegenerative diseases by glutathione and phase ii detoxification enzymes |
| 01/10/2002 | WO2002002189A2 Cellulose sulfate and other sulfated polysaccharides to prevent and treat papilloma virus infection and other infections |
| 01/10/2002 | WO2002002135A1 Preventives and remedies for diseases in association with demyelination |
| 01/10/2002 | WO2002002118A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 01/10/2002 | WO2002002109A1 Use of galiella lactone |
| 01/10/2002 | WO2002002105A1 Therapeutic combinations of fatty acids |
| 01/10/2002 | WO2002002097A2 Methods for treating seizure disorders by inhibiting mapk pathway activation with nitriles |
| 01/10/2002 | WO2002002091A2 Methods and compositions for the treatment of alcoholism and alcohol dependence |
| 01/10/2002 | WO2002002090A2 Inhibitors of copper-containing amine oxidases |
| 01/10/2002 | WO2002002085A2 Rapidly-decomposing administrable form for releasing active ingredients in the oral cavity or in bodily cavities |
| 01/10/2002 | WO2002001969A1 Vitamin k and essential fatty acids |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001070813A3 REGULATION OF HUMAN GluR5-LIKE RECEPTOR |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001056993A3 Pyrazole compositions useful as inhibitors of erk |
| 01/10/2002 | WO2001052855A3 Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone |
| 01/10/2002 | WO2001046398A3 Aspartyl proteases |
| 01/10/2002 | WO2001043697A3 Analogs of galanthamine and lycoramine as modulators of nicotinic receptors |
| 01/10/2002 | WO2001043691A3 Fragments and antagonists of heat shock protein 60 |
| 01/10/2002 | WO2001037785A3 Novel methods and compositions involving opioids and antagonists thereof |
| 01/10/2002 | WO2001036425A3 Imidazole compounds used as phosphodiesterase vii inhibitors |
| 01/10/2002 | WO2001034604A3 Adenosine receptor antagonists and methods of making and using the same |
| 01/10/2002 | WO2001034603A3 Bicyclic and tricyclic heteroaromatic compounds |
| 01/10/2002 | WO2000061138A8 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004586 Prion-binding activity in serum and proteins |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004528 Method for the treatment of insomnia |
| 01/10/2002 | US20020004527 Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof |
| 01/10/2002 | US20020004525 Reduce fluid pressure of nerve sheath using prostaglandins |
| 01/10/2002 | US20020004520 Crystalline(-)-3r,4r-trans-7methoxy-2,2-dimethyl-3-phenyl-4-{4-[2- (pyrrolidin-1-yl)ethoxy]pheny 1}chromane, hydrogen malete |
| 01/10/2002 | US20020004513 Azacyclic compounds |
| 01/10/2002 | US20020004509 Method of preventing abuse of opioid dosage forms |
| 01/10/2002 | US20020004498 Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004484 Topical anesthetic/opioid formulations and uses thereof |
| 01/10/2002 | US20020004208 Generating nicotine antibodies in situ |
| 01/10/2002 | US20020004194 Detecting modulators of proteins associated with ionic mobility; obtain cell, incubate with amyloid protein, monitor cells for reduced ionic mobility |
| 01/10/2002 | US20020004049 Tryptophan source from plants and uses therfor |
| 01/10/2002 | US20020004039 Stimulating proliferation of neural progenitor cells with epidermal growth factor binding polypeptide; directing migration of progeny to neurological injury sight; stimulating cell differentiation at injury |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10030345A1 Hochkonzentrierte stabile Meloxicamlösungen Highly concentrated stable meloxicam |
| 01/10/2002 | DE10019714A1 Salze von bicyclischen, N-acylierten Imidazo-3-aminen und Imidazo-5-aminen Salts of bicyclic, N-acylated imidazo-3-amines and imidazo-5-amines |